Celularity Inc. Class A Common Stock

€1.599
EUR
Last updated on --.
24h volume18.56K
24h highest1.5998 EUR
24h lowest1.4445 EUR
24h Price movement+0.27%

CELU recent prices

24 Hours
+0.27%+€0.004312
30 days
+180.98%+€1.030
60 days
+153.35%+€0.81954
90 days
+81.86%+€0.7201

Key data

Previous close1.5954 EUR
Market cap39.44M EUR
Volume18.56K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.7338 EUR
Net income (FY)-79.10M EUR
Revenue (FY)22.90M EUR
Last report dateApr 30, 2026

About Celularity Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersFLORHAM PARK
Employees (FY)115.00
Revenue per employee (FY)199.10K EUR
Net income per employee (FY)-687.79K EUR
Listed onNasdaq
Official website

CELU conversion tables

CELUCELU
EUREUR
0.5 CELU0.79988 EUR
1 CELU1.599 EUR
5 CELU7.998 EUR
10 CELU15.99 EUR
EUREUR
CELUCELU
0.5 EUR0.31255 CELU
1 EUR0.6251 CELU
5 EUR3.125 CELU
10 EUR6.250 CELU

FAQ

CELU is trading at €1.599, +0.27% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CELU stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CELU is currently trading at €1.599, +0.27% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CELU price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CELU's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CELU; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CELU's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Celularity Inc. Class A Common Stock's market cap is currently 39.44M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume18.56K
24h highest1.5998 EUR
24h lowest1.4445 EUR
24h Price movement+0.27%
CELUCELU
EUREUR
Start trade with CELU Perpetual